Every year 2.5 million individuals become newly infected with HIV. This 
highlights that current ways for prevention of transmission, such as use 
of condoms, are not sufficient to limit the spread of HIV infection. 
Novel prevention strategies using antiretroviral drugs are being 
developed. One of these strategies is pre-exposure prophylaxis (PrEP) 
with antiretroviral drugs. The effect of drug resistance will be a 
critical issue in the use of PrEP. Drug resistance will reduce the 
effectiveness of PrEP. This detrimental effect could be counterbalanced 
by the reduced fitness of drug-resistant HIV, which may result in lower 
levels of virus particles. Because the amount of virus is a major 
determinant of the risk of transmission, drug-resistant HIV could be 
transmitted less easily. During the seminar I will discuss that the 
benefits of PrEP are expected to outweigh the risks associated with drug 
resistance (1.2). Another prevention strategy is “test and treat” in 
which testing positive for HIV is followed by treatment. HIV-testing can 
prevent new infections as individuals aware of their HIV-status can 
reduce their risk behaviour. Treatment of infected individuals can 
prevent new infections, as antiretroviral drugs can suppress the amount 
of virus to undetectable levels. Mathematical modelling has predicted 
that universal HIV testing followed by immediate start of antiretroviral 
drugs for those individuals who test positive, could reduce the HIV 
pandemic to one incident case of HIV per 1000 people within a decade 
(3). But, universal testing and immediate treatment may not be achieved 
in clinical practice in Africa (4) where most new infections occur 
World-wide. We used realistic data from a rural hospital in Macha in 
Zambia and used assumptions about testing and treatment that can be 
achieved in clinical practice. Using mathematical modelling we found 
that “test and treat” can strongly reduce the incidence of HIV but 
cannot eliminate the epidemic. “Test and treat” will lead to an 
increased prevalence of HIV as infected individuals will live longer.
                
              
              
              
              
              
                
Coffee and cookies will be served 15 minutes before the start of the seminar
Detalles de contacto:
Ernesto M. Nicola Contact form